Carcinoma, Embryonal - 21 Studies Found
| Recruiting |
: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors :
: Drug: Brentuximab Vedotin Both cohorts will be treated similarly and in parallel but analyzed separately |
| Completed |
: Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer :
|
| Recruiting |
: Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors :
|
| Completed |
: Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors :
: |
| Recruiting |
: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings :
|
| Active, not recruiting |
: Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors :
|
| Completed |
: MEN-10755 in Treating Patients With Solid Tumors :
: 1999-11-01 : Drug: sabarubicin |
| Active, not recruiting |
: Brentuximab Vedotin (SGN-35) as Salvage Treatment for CD30-positive Germ Cell Tumors : Germ Cell Cancer : 2013-04-20 : Drug: Brentuximab Vedotin Intravenous Brentuximab Vedotin at the dose of 1.8 mg/Kg every 3 weeks until d |
| Active, not recruiting |
: Combination Chemotherapy in Treating Men With Germ Cell Cancer :
|
| Completed |
: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer :
|